Lymphology

Aims & Scope

The Journal contains original articles, special features (see below), and information regarding the International Society of Lymphology.

It seeks original papers dealing with clinical and basic studies of the lymphatic system and its disorders including related fields.

Articles are accepted for external review and publication on the condition that they are contributed to Lymphology only and that no substantial part has been or will be published elsewhere.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	0.6

SJR (SCImago Journal Rank)

Year	Value
2024	0.253

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	53

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• THE DIAGNOSIS AND TREATMENT OF PERIPHERAL LYMPHEDEMA: 2023 CONSENSUS DOCUMENT OF THE INTERNATIONAL SOCIETY OF LYMPHOLOGY

  Citation: 16

  Authors: 2023

• DOES LIPOSUCTION FOR LYMPHEDEMA WORSEN LYMPHATIC INJURY?

  Citation: 9

  Authors: W.F., S.K., J.N.

• SHORT DURATION OF UPPER EXTREMITY LYMPHEDEMA CORRELATES WITH A FAVORABLE CYTOKINE RESPONSE AFTER LYMPH NODE TRANSFER SURGERY

  Citation: 5

  Authors: E.H., I.-M., M., A., P.

• TREATMENT OF SECONDARY LOWER LIMB LYMPHEDEMA AFTER GYNECOLOGIC CANCER WITH COMPLEX DECONGESTIVE THERAPY

  Citation: 5

  Authors: F., N., L., J., L., Z., D.

• RISK FACTORS FOR DEVELOPING UPPER LIMB CELLULITIS AFTER BREAST CANCER TREATMENT

  Citation: 5

  Authors: O., E., E., B., E.

• ADDITION OF LOCAL CRYOTHERAPY FOR TREATMENT OF POST-MASTECTOMY LYMPHEDEMA

  Citation: 5

  Authors: Z.M., M.

• THERAPEUTIC THORACIC DUCT DRAINAGE: A SYSTEMATIC REVIEW OF THE EASTERN EUROPEAN EXPERIENCE AND FUTURE POTENTIAL

  Citation: 4

  Authors: P.S., S., V.E,, S., G., J., N.D., M., A.R.J., J.A.

• PREVALENCE OF CLINICAL MANIFESTATIONS AND ORTHOPEDIC ALTERATIONS IN PATIENTS WITH LIPEDEMA: A PROSPECTIVE COHORT STUDY

  Citation: 4

  Authors: I., M.V., A., A.B., J.

• IATROGENIC SYSTEMIC LYMPHEDEMA FOLLOWING MULTIPLE MYELOMA TREATMENT

  Citation: 2

  Authors: S., J., A.K., G., A.C.

• COMPOUND HETEROZYGOSITY FOR A VARIABLY PENETRANT VARIANT AND A VARIANT OF UNKNOWN SIGNIFICANCE IN FLT4 CAUSES FULLY PENETRANT MILROY'S LYMPHEDEMA

  Citation: 2

  Authors: J., S.Y.

---